Thyroid cancer is a type of cancer that affects the thyroid gland, which is located at the base of the neck. It is one of the most common types of endocrine cancers, and it affects more women than men. The good news is that thyroid cancer is highly treatable, and there are several drugs available that can help manage the disease.
Read More: https://www.coherentmarketinsights.com/market-insight/thyroid-cancer-drugs-market-1710
Thyroid hormone replacement therapy: After the removal of the thyroid gland, the patient needs to take thyroid hormone replacement therapy for the rest of their life. This is because the thyroid hormone is responsible for regulating metabolism, and without it, the body cannot function properly. The most commonly prescribed thyroid hormone replacement therapy is levothyroxine.
Tyrosine kinase inhibitors (TKIs): TKIs are a type of drug that block the activity of proteins called tyrosine kinases, which are involved in the growth and spread of cancer cells. TKIs can be used to treat advanced or metastatic thyroid cancer that has not responded to other treatments. Examples of TKIs used in the treatment of thyroid cancer include sorafenib, lenvatinib, and cabozantinib.
Radioactive iodine (RAI): RAI is a type of therapy that involves the ingestion of radioactive iodine, which is absorbed by the thyroid gland and destroys cancer cells. This treatment is most effective for papillary and follicular thyroid cancer, which are the most common types of thyroid cancer. RAI is typically used after surgery to remove the thyroid gland, as it can destroy any remaining cancer cells.
Chemotherapy: Chemotherapy is a type of treatment that uses drugs to kill cancer cells. It is typically used for advanced or metastatic thyroid cancer that has not responded to other treatments. However, chemotherapy is not as effective for thyroid cancer as it is for other types of cancer, and it is usually only used in combination with other treatments.
Immunotherapy: Immunotherapy is a type of treatment that stimulates the body's immune system to fight cancer cells. Immunotherapy drugs called checkpoint inhibitors are sometimes used to treat advanced or metastatic thyroid cancer that has not responded to other treatments. Checkpoint inhibitors work by blocking the activity of proteins that prevent the immune system from attacking cancer cells.
In conclusion, the treatment of thyroid cancer typically involves a combination of surgery, radiation therapy, and drug therapy. The drugs used in the treatment of thyroid cancer include thyroid hormone replacement therapy, tyrosine kinase inhibitors, radioactive iodine, chemotherapy, and immunotherapy. The choice of drug therapy depends on the type and stage of thyroid cancer, as well as the individual patient's health and medical history. It is important for patients with thyroid cancer to discuss their treatment options with their healthcare provider to determine the best course of action.
A recent report published by TheBusinessResearchCompany on Thyroid Cancer Drugs Market provides in-depth analysis of segments and sub-segments in the global as well as regional.The Thyroid Cancer Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global thyroid cancer drugs market.
The report covers the thyroid cancer drugs market’s segments- Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, hospitals, oncology clinics, research organizations, radioiodine ablation, thyroid stimulating hormone (THS) suppression, chemotherapy, targeted multikinase therapy, and others.Thyroid Cancer Drugs Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It also compares the market’s historic and forecast growth.
It covers all the regions, key developed countries and major emerging markets.
It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
